PHARMACOKINETICS OF DISOPYRAMIDE IN PATIENTS WITH CHRONIC-RENAL-FAILURE

被引：7

作者：

FRANCOIS, B ^{[1
]}

MALLEIN, R ^{[1
]}

RONDELET, J ^{[1
]}

LUSSIGNOL, M ^{[1
]}

机构：

[1] HOP ANTIQUAILLE,DEPT CLIN BIOCHEM,F-69005 LYON,FRANCE

来源：

EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS | 1983年 / 8卷 / 01期

关键词：

D O I：

10.1007/BF03189585

中图分类号：

R9 [药学];

学科分类号：

1007 [药学];

摘要：

引用

页码：85 / 92

页数：8

共 23 条

[1]

ENHANCED METABOLISM AND DIMINISHED EFFICACY OF DISOPYRAMIDE BY ENZYME-INDUCTION [J].

AITIO, ML ;

VUORENMAA, T .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 9 (02) :149-152

[2]

DISOPYRAMIDE SERUM AND PHARMACOLOGIC EFFECT KINETICS APPLIED TO ASSESSMENT OF BIOAVAILABILITY [J].

BRYSON, SM ;

WHITING, B ;

LAWRENCE, JR .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 6 (05) :409-419

[3]

LINEAR RELATIONSHIPS BETWEEN PLASMA BINDING AND LIPOPHILICITY OF DISOPYRAMIDE DERIVATIVES [J].

CHIEN, YW ;

LAMBERT, HJ ;

LIN, TK .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1975, 64 (06) :961-966

[4]

EFFECTS OF URINE PH AND PLASMA-PROTEIN BINDING ON RENAL CLEARANCE OF DISOPYRAMIDE [J].

CUNNINGHAM, JL ;

SHEN, DD ;

SHUDO, I ;

AZARNOFF, DL .

CLINICAL PHARMACOKINETICS, 1977, 2 (05) :373-383

[5]

GARRETT ER, 1975, CLIN PHARMACOL THER, V17, P234

[6]

PHARMACODYNAMICS OF ANTIARRHYTHMIC DISOPYRAMIDE IN HEALTHY HUMANS - CORRELATION OF KINETICS OF DRUG AND ITS EFFECTS [J].

HINDERLING, PH ;

GARRETT, ER .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1976, 4 (03) :231-242

[7]

PROTEIN-BINDING AND ERYTHROCYTE PARTITIONING OF DISOPYRAMIDE AND ITS MONODEALKYLATED METABOLITE [J].

HINDERLING, PH ;

BRES, J ;

GARRETT, ER .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1974, 63 (11) :1684-1690

[8]

ILETT KF, 1979, CLIN PHARMACOL THER, V26, P1

[9]

PHARMACOKINETICS OF ORAL DISOPYRAMIDE PHOSPHATE IN PATIENTS WITH RENAL IMPAIRMENT [J].

JOHNSTON, A ;

HENRY, JA ;

WARRINGTON, SJ ;

HAMER, NAJ .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 10 (03) :245-248

[10]

KARIM A, 1975, ANGIOLOGY, V26, P85

← 1 2 3 →